{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:49:49Z","timestamp":1769158189498,"version":"3.49.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"he Open Research Project of Key Laboratories in Jiangsu Province Universities","award":["he Open Research Project of Key Laboratories in Jiangsu Province Universities"],"award-info":[{"award-number":["he Open Research Project of Key Laboratories in Jiangsu Province Universities"]}]},{"name":"the Guiding planning Project of Qinghai Health Commission","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This systematic review studied and compared the safety and efficacy of glucocorticoids (GCs)\u2005+\u2005cyclophosphamide (CTX) and GCs\u2005+\u2005tacrolimus (TAC) therapies for treating children with Henoch-Sch\u00f6nlein purpura nephritis (HSPN).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The data on GCs\u2005+\u2005CTX and GCs\u2005+\u2005TAC therapies for HSPN children were procured from the EMbase, China National Knowledge Infrastructure, the Cochrane Library, PubMed, and Wanfang from the inception to May 10, 2024.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This review included 5 studies (2 non-randomized and 3 randomized controlled trials), comprising 363 patients. Furthermore, the complete remission within 6 months in the TAC group (43.3%) was higher than that in CTX group (26.2%) and the total remission within 6 months in the TAC (76.7%) was higher than that in CTX groups (54.1%). Moreover, in terms of adverse reactions, the incidence of hypertension in TAC group was higher than that in CTX group, whereas the incidences of other adverse reactions such as liver function injury, hyperglycemia, myelosuppression and gastrointestinal discomfort in TAC group were lower than that in CTX group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This systematic review indicated that for HSPN children, the TAC therapy may have relatively higher remission rate and fewer adverse reactions than the CTX therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043358","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:01:29Z","timestamp":1753156889000},"page":"e43358","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of tacrolimus versus cyclophosphamide therapy for Henoch\u2013Sch\u00f6nlein purpura nephritis in children: A systematic review"],"prefix":"10.1097","volume":"104","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"},{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changle","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuya","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanxin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fancheng","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuoji","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weigang","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7783-2709","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, Jiangsu, China"},{"name":"Department of Nephrology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China"},{"name":"Department of Internal Medicine, People\u2019s Hospital of Hainan Tibetan Autonomous Prefecture, Hainan Tibetan Autonomous Prefecture, Qinghai, China"},{"name":"Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/18756336MTA2lNDYc2","article-title":"Henoch-Sch\u00f6nlein purpura in children: an updated review.","volume":"16","author":"Leung","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"e0270796","DOI":"10.1371\/journal.pone.0270796","article-title":"Epidemiology of biopsy-proven Henoch-Sch\u00f6nlein purpura nephritis in children: a nationwide survey in Japan.","volume":"17","author":"Terano","year":"2022","journal-title":"PLoS One"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00467-013-2550-4","article-title":"Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Sch\u00f6nlein purpura nephritis.","volume":"28","author":"Davin","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R4-20250722","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(02)09835-5","article-title":"The adult kidney 24 years after childhood Henoch-Sch\u00f6nlein purpura: a retrospective cohort study.","volume":"360","author":"Ronkainen","year":"2002","journal-title":"Lancet"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.ajkd.2006.02.178","article-title":"Predictors of outcome in Henoch-Sch\u00f6nlein nephritis in children and adults.","volume":"47","author":"Coppo","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/PHMT.S379862","article-title":"Diagnostic and management strategies of IgA vasculitis nephritis\/Henoch-Sch\u00f6nlein purpura nephritis in pediatric patients: current perspectives.","volume":"14","author":"Sestan","year":"2023","journal-title":"Pediatric Health Med Ther"},{"key":"R7-20250722","first-page":"647","article-title":"Evidence-based guidelines for the diagnosis and treatment of pediatric Henoch-Sch\u00f6nlein purpura nephritis.","volume":"55","year":"2017","journal-title":"Chin J Pediatr"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2015.09.006","article-title":"Tacrolimus use in lupus nephritis: a systematic review and meta-analysis.","volume":"15","author":"Hannah","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40265-016-0683-z","article-title":"Efficacy and safety of tacrolimus versus cyclophosphamide for primary membranous nephropathy: a meta-analysis.","volume":"77","author":"Zhu","year":"2017","journal-title":"Drugs"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11255-022-03122-7","article-title":"Efficacy and safety of tacrolimus versus corticosteroid as initial monotherapy in adult-onset minimal change disease: a meta-analysis.","volume":"54","author":"Lu","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40272-022-00506-1","article-title":"Efficacy and safety of tacrolimus in the treatment of pediatric Henoch-Sch\u00f6nlein purpura nephritis.","volume":"24","author":"Wu","year":"2022","journal-title":"Paediatr Drugs"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/iju.14665","article-title":"Effect and safety evaluation of tacrolimus and tripterygium glycosides combined therapy in treatment of Henoch-Sch\u00f6nlein purpura nephritis.","volume":"28","author":"Zhang","year":"2021","journal-title":"Int J Urol"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"R14-20250722","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/BRS.0000000000001061","article-title":"2015 Updated method guideline for systematic reviews in the Cochrane back and neck group.","volume":"40","author":"Furlan","year":"2015","journal-title":"Spine"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R16-20250722","first-page":"60","article-title":"Effect analysis of tacrolimus on Henoch-Sch\u00f6nlein purpura nephritis with nephritic syndrome.","volume":"10","author":"Wu","year":"2020","journal-title":"Front Med"},{"key":"R17-20250722","first-page":"19","article-title":"Clinical efficacy of tacrolimus combined with glucocorticoid in the treatment of children with Henoch Schonlein purpura nephropathy and their effects on immune function and serum sICAM-1.","volume":"35","author":"Zhang","year":"2022","journal-title":"Clin Misdiagn Misther"},{"key":"R18-20250722","first-page":"728","article-title":"Comparative study of tacrolimus and cyclophosphamide combined with hormone therapy for children with III ~ IV purpura nephritis.","volume":"23","author":"Chen","year":"2022","journal-title":"Chin J Integr Tradit West Nephrol"},{"key":"R19-20250722","first-page":"815","article-title":"Clinical effect of tacrolimus for Henoch-Sch\u00f6nlein purpura nephritis in children.","volume":"34","author":"Zhang","year":"2017","journal-title":"J Xinxiang Med Univ"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12906-021-03415-x","article-title":"Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials.","volume":"21","author":"Xue","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12969-017-0146-4","article-title":"A single-center analysis of Henoch-Schonlein purpura nephritis with nephrotic proteinuria in children.","volume":"15","author":"Feng","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"R22-20250722","first-page":"1113","article-title":"Therapeutic effect of mycophenolate mofetil or cyclophosphamide in children with Henoch-Sch\u00f6nlein purpura nephritis of different age groups.","volume":"25","author":"Du","year":"2023","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R23-20250722","first-page":"1140","article-title":"Clinical research of mycophenolate mofetil and cyclophosphamide in the treatment of children Henoch-Schonlein purpura nephritis accompanied by nephrofic syndrome.","volume":"50","author":"Miao","year":"2015","journal-title":"Jiangxi Med J"},{"key":"R24-20250722","first-page":"352","article-title":"Treatment of children Henoch-Schonlein purpura nephritis with mycophenolate mofetil and cyclophosphamide.","volume":"39","author":"Du","year":"2010","journal-title":"J China Med Univ"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1620\/tjem.227.281","article-title":"A meta-analysis of randomized controlled trials comparing tacrolimus with intravenous cyclophosphamide in the induction treatment for lupus nephritis.","volume":"227","author":"Deng","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/0886022X.2021.1914655","article-title":"Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.","volume":"43","author":"Huang","year":"2021","journal-title":"Ren Fail"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/HYPERTENSIONAHA.122.19189","article-title":"Tacrolimus causes hypertension by increasing vascular contractility via RhoA (Ras Homolog Family Member A)\/ROCK (rho-associated protein kinase) pathway in mice.","volume":"79","author":"Wang","year":"2022","journal-title":"Hypertension"},{"key":"R28-20250722","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/HYPERTENSIONAHA.111.172320","article-title":"Tacrolimus-induced hypertension: what\u2019s endothelial and hematopoietic FKBP12 got to do with it?","volume":"57","author":"Didion","year":"2011","journal-title":"Hypertension"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:01:33Z","timestamp":1753156893000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":28,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043358","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}